ALFA Finder| Revenue growth | FY26 revenue reached ₹3,420cr, up 13.8% YoY. |
|---|---|
| Margins | Gross margins expanded 321bps to 54.3% in FY26. |
| Order book | 8-10 innovators in pipeline for life cycle management products. |
| Demand visibility | Strong traction in animal health and specialty CDMO life cycle management. |
| Management confidence | High; internal EBITDA target of ₹1,000cr pulled forward to FY27. |
Growth
FY26 Revenue grew 13.8% to ₹3,420cr; EBITDA jumped 59.6% to ₹702cr; PAT surged 14x to ₹225cr.
Outlook
Targeting 15-20% revenue growth; aim to hit ₹1,000cr EBITDA in FY27/28 via CDMO and R&D expansion.
Risks
Potential margin volatility from raw material/solvent availability and freight costs; intense generic competition in US markets.
Earnings Call filed with BSE, NSE: VIYASH. Summary written with AI assistance from the document.
Viyash Scientific Ltd: key numbers
- Share price
- ₹255.33
- Market cap
- ₹11,285 Cr
- Revenue (annual)
- ₹3,420 Cr
- Net profit (annual)
- ₹177.3 Cr
- P/E (TTM)
- 65.9×Sector 43.8×
- Promoter holding
- 49.24%-12.07% QoQ
- FII holding
- 2.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Viyash Scientific Ltd
All →Viyash Scientific Employee Stock Options
Viyash Scientific allotted 228,408 shares under two employee stock option schemes. Paid-up capital rose to 44,19,91,958 shares of Rs.2 each.
Viyash Scientific Board Meeting Date
Viyash Scientific will hold a board meeting on 13 November 2026 to consider unaudited quarterly and half-yearly results. The trading window remains closed until 15 November 2026.
Viyash Scientific Merger & Restructuring Worth ₹3.8 Cr
Viyash's step-down subsidiary Alivira Vietnam was incorporated on 30 October 2026, with investment up to USD 400,000. It will distribute animal health products and APIs in Vietnam.
- Value
- ₹3.80 Cr
Viyash Scientific Management Change
Viyash Scientific Limited has appointed Dr. Mallikharjuna Rao Nagineni as Senior Vice President, Human Resources, succeeding the retiring Mr. Prasad Lad.
Viyash Scientific Capital Structure Change
White Oak Capital Management Consultants LLP disclosed the sale of 8,747,392 equity shares of Viyash Scientific Ltd, reducing its stake in the open market.
Viyash Scientific Other Announcement
Viyash Scientific Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.